Effect of skin rash on patient’s acceptance of cancer therapies
Research type
Research Study
Full title
Effect of skin rash on patient’s acceptance of cancer therapies
IRAS ID
160701
Contact name
Stephen FALK
Contact email
Sponsor organisation
Merck KGaA
Duration of Study in the UK
1 years, 0 months, 0 days
Research summary
Some cancer treatments can cause patients to suffer from a skin rash as a side-effect. This study has been designed to find out how suffering from skin rash, and other side-effects affects patients’ everyday lives and how much they accept side-effects as part of their cancer treatment. We will ask patients who are suffering from certain types of cancer of their lungs, bowls, head and neck or pancreas about the side-effects of their treatment. We want to find out how they compare skin rash to other side-effects of their treatment such as feeling tired, pale skin, weakness, shortness of breath, chest pain, more infections than normal, headache and dizziness, hair loss and feeling sick.
We also want to find out about how and what doctors tell their patients about side-effects when they are treated with certain types of medicine for their cancer.
We will obtain this information by interviewing around 200 cancer patients who will answer up to 47 questions during interviews either over the phone or face to face. Interviews will be guided by a questionnaire. Patients will be recruited at sites in Spain, UK, USA, Germany, France and Italy. 20 patients will take part in the study in the UK. All patients will have the study thoroughly explained to them and they will sign a consent form before they participate. We will not be able to identify patients from their questionnaires and their care team will not be able to see what they said to us during the interview. Patients will receive £50 as compensation for their time as taking part in this study is not part of their normal care. Around 20 doctors will also be interviewed in each of the counties.
REC name
North East - York Research Ethics Committee
REC reference
14/NE/1231
Date of REC Opinion
28 Nov 2014
REC opinion
Favourable Opinion